Company / Working Capital per Share
Regeneron Pharmaceuticals Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$120.08
FY2025
5-year range
$87.98 / $143.10
FY2021-FY2025
Trend
-7.4%
vs FY2024
Sector context
#5 of 210
Health Care
What the data says
Among 210 Health Care companies, Regeneron Pharmaceuticals is in the top 2% for working capital per share. Declined from $143.10 to $120.08 over the past 2 years.
Based on SEC 10-K filings.
120.08 in FY2025 with a 5-year CAGR of +14.3%. Top quartile in the Health Care sector.
Declined from $143.10 to $120.08 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- +14.3%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 210This company $120.08 Sector average $146.86
▼
-18.2% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 7.4% year-over-year.
- Ranks #5 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $120.08 | -7.4% |
| FY2024 | $129.66 | -9.4% |
| FY2023 | $143.10 | +29.3% |
| FY2022 | $110.71 | +25.8% |
| FY2021 | $87.98 | +42.6% |
| FY2020 | $61.69 | +27.8% |
| FY2019 | $48.25 | +12.1% |
| FY2018 | $43.03 | +55.0% |
| FY2017 | $27.77 | +62.4% |
| FY2016 | $17.09 | -9.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026